Igm Monoclonal And Nervous System Disorders
Mouse Anti Human Macrophage (Tissue And Proliferative Disorders) Monoclonal Antibody |
|||
DMABT-52185MH | Creative Diagnostics | 0.5 ml | 1226.4 EUR |
Human IgG antibody Laboratories manufactures the igm monoclonal and nervous system disorders reagents distributed by Genprice. The Igm Monoclonal And Nervous System Disorders reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm monoclonal. Other Igm products are available in stock. Specificity: Igm Category: Monoclonal Group: And Nervous
Skin Dissociation System 1 (Dermal fibroblast and keratinocytes), Mouse and Rat |
||
CHI Scientific | ea | Ask for price |
HiTrap Albumin and IgG Depletion |
||
Creative BioMart | 2 × 1 mL | 2768 EUR |
Description: Chromatography Reagents |
||
Albumin and IgG Depletion SpinTrap |
||
Creative BioMart | 10 columns | 1864 EUR |
Description: Chromatography Reagents |
||
Gel and PCR Extraction System (100 preps) |
||
Bio Basic | 100preps | 180.06 EUR |
Gel and PCR Extraction System (200 Preps) |
||
Bio Basic | 200preps, 200prep | 263.58 EUR |
Human Monoclonal Anti-Falvivirus (Ebola and Marburg virus glycoprotein, GP) IgG (Neutralzing) |
||
Alpha Diagnostics | 100 ul | 578.4 EUR |
Human Anti centriole and centrosome antibody IgG ELISA kit |
||
BlueGene | 192 tests | 1524 EUR |
Description: A competitive ELISA for quantitative measurement of Human Anti centriole and centrosome antibody IgG in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), 1mg/mL |
|||
BNUM3793-50 | Biotium | 1uL | 396 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), 0.2mg/mL |
|||
BNUB3792-100 | Biotium | 1uL | 225 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), 0.2mg/mL |
|||
BNUB3792-500 | Biotium | 1uL | 485 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), 0.2mg/mL |
|||
BNUB3793-100 | Biotium | 1uL | 225 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), 0.2mg/mL |
|||
BNUB3793-500 | Biotium | 1uL | 485 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF647 conjugate, 0.1mg/mL |
|||
BNC473792-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF647 conjugate, 0.1mg/mL |
|||
BNC473792-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF647 conjugate, 0.1mg/mL |
|||
BNC473793-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF647 conjugate, 0.1mg/mL |
|||
BNC473793-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF568 conjugate, 0.1mg/mL |
|||
BNC683792-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF568 conjugate, 0.1mg/mL |
|||
BNC683792-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF568 conjugate, 0.1mg/mL |
|||
BNC683793-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF568 conjugate, 0.1mg/mL |
|||
BNC683793-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF594 conjugate, 0.1mg/mL |
|||
BNC943792-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF594 conjugate, 0.1mg/mL |
|||
BNC943792-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF594 conjugate, 0.1mg/mL |
|||
BNC943793-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF594 conjugate, 0.1mg/mL |
|||
BNC943793-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |